Product identity before price
A nasal product subscription and one-time package, with explicit limits on what the public evidence establishes.
Inspect the terms, then compare
Sorting compares displayed numbers only. Billing units, routes, supply periods and included services can differ. Unpriced records sort last. Care-only prices exclude medication. Featured placements above are separate.
The selected subscription option is $159 for a provider-stated one-month supply. Clinical consultation and prescription eligibility apply.
The selected one-time option is $199 for a provider-stated one-month supply. Clinical consultation and prescription eligibility apply.
No matching offers. Try another filter.
VIP is marketed by the listed provider as a nasal preparation. The commercial page does not establish clinical benefit for an individual or FDA approval of that product. An FDA orphan designation for VIP in acute respiratory distress syndrome is not an approval for a wellness spray. Ask for the dispensed formulation, pharmacy, indication and care requirements.
Sources: Joi + Blokes — VIP, FDA — VIP orphan designation record, FDA — compounding questions and answers
Follow the evidence
Each source retains its own check date. Provider pages document advertised terms; they do not independently establish clinical outcomes.
Rendered product page: $159 subscription or $199 one-time for one month. The provider describes a nasal spray; these are commercial terms, not independently verified benefit claims.
Checked October 9, 2026
The ARDS orphan designation record says not FDA approved for the orphan indication. Designation does not establish approval of a nasal wellness product.
Checked October 9, 2026
Clinical and regulatory context. A compounded preparation is not FDA-approved.
Checked October 8, 2026